Free Trial

FibroBiologics (FBLG) SEC Filings & 10K Form

FibroBiologics logo
$0.62 +0.03 (+5.30%)
Closing price 04:00 PM Eastern
Extended Trading
$0.62 0.00 (-0.06%)
As of 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent FibroBiologics SEC Filings

DateFilerForm TypeView
07/17/2025
6:54 PM
BlackRock, Inc. (Filed by)
FibroBiologics (Subject)
Form SCHEDULE 13G/A
06/12/2025
6:30 PM
FibroBiologics (Issuer)
Niklas Victoria Ninon Olivia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
6:16 PM
Cilento Richard C. Jr. (Reporting)
FibroBiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
6:20 PM
Coen Stacy Ann (Reporting)
FibroBiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
6:23 PM
FibroBiologics (Issuer)
Hoffman Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
6:26 PM
FibroBiologics (Issuer)
Link Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
2:13 PM
FibroBiologics (Subject)
Newlin Michael F. (Filed by)
Form SCHEDULE 13G
05/27/2025
4:56 PM
FibroBiologics (Issuer)
Khoja Hamid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2025
5:01 AM
FibroBiologics (Filer)
Form DEF 14A
04/23/2025
5:05 AM
FibroBiologics (Filer)
Form DEFA14A
04/23/2025
5:10 AM
FibroBiologics (Filer)
Form ARS
03/31/2025
3:04 PM
FibroBiologics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/10/2025
11:15 PM
FibroBiologics (Filer)
Form EFFECT
02/07/2025
4:24 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
8:19 AM
FibroBiologics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/30/2025
11:43 AM
BlackRock, Inc. (Filed by)
FibroBiologics (Subject)
Form SCHEDULE 13G/A
01/29/2025
3:43 PM
BlackRock, Inc. (Filed by)
FibroBiologics (Subject)
Form SCHEDULE 13G
01/21/2025
11:15 PM
FibroBiologics (Filer)
Form EFFECT
01/14/2025
11:15 PM
FibroBiologics (Filer)
Form EFFECT
01/14/2025
3:34 PM
FibroBiologics (Filer)
Form 424B4
01/10/2025
4:22 PM
FibroBiologics (Filer)
Form S-1/A
12/31/2024
3:20 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
3:18 PM
FibroBiologics (Issuer)
GARCIA RUBEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:20 PM
FibroBiologics (Issuer)
Khoja Hamid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:21 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
7:29 AM
FibroBiologics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/23/2024
7:00 AM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
4:15 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
8:33 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:58 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
3:01 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FBLG) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners